Belmar Research

New clinical literature aimed at improving the most difficult challenges facing healthcare
AGI & Disease Morbidity
We believe in AI. One critical set of technologies that have the potential to shape the future of healthcare are highly sophisticated autonomous systems that can perform certain kinds of routine tasks far more quickly and efficiently than humans.
They are an incredible assist for the providers and technology delivering care. Those technologies fall under the umbrella of Artificial General Intelligence (AGI), and Belmar Health conducts ongoing research contributing to the advancement and refinement of AGI. The current focus of our research is increasing the accuracy and clinical efficacy of disease prognosis, with the goal of reducing morbidity and mortality rates for leading causes of death such as heart disease and cerebrovascular disease. Our work is embedded in a strict set of safety, ethics, and reliability guidelines: the systems we build will never replace physicians, instead providing intensive support in specific clinical use cases. We plan to deploy our research initially in a primary care setting.
© Belmar Health LLC 2022. All rights reserved.
Legal